TITLE

Association of subarachnoid hemorrhage and phentermine usage: Coincidence, not causation

AUTHOR(S)
Hendricks, Ed J.; Rothman, Richard B.; Bryman, David A.; Schmidt, Stacy L.
PUB. DATE
March 2015
SOURCE
Journal of the American Pharmacists Association: JAPhA;Mar/Apr2015, Vol. 55 Issue 2, p122
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter to the Editor
ABSTRACT
A letter to the editor is presented in response to the article "Subarachnoid Hemorrhage in a Patient Taking Phentermine for Weight Loss," by J. A. Brain, published in a 2014 issue.
ACCESSION #
101729060

 

Related Articles

  • Response: Association of subarachnoid hemorrhage and phentermine usage. Bain, Jonathan A.; Cook, Aaron M. // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2015, Vol. 55 Issue 2, p124 

    A response by Jonathan A. Bain and Aaron M. Cook to a letter to the editor about their article "Subarachnoid Hemorrhage in a Patient Taking Phentermine for Weight Loss," published in a 2014 issue, is presented.

  • Phentermine.  // Reactions Weekly;Oct2014, Vol. 1523 Issue 1, p152 

    An abstract of the article "Subarachnoid hemorrhage in a patient taking phentermine for weight loss," by J. A. Bain and colleagues is presented.

  • Subarachnoid hemorrhage in a patient taking phentermine for weight loss. Bain, Jonathan A.; Dority, Jeremy S.; Cook, Aaron M. // Journal of the American Pharmacists Association: JAPhA;Sep/Oct2014, Vol. 54 Issue 5, p548 

    Objective: To report the case of an angiography-negative subarachnoid hemorrhage (SAH) in association with increased use of the sympathomi-metic phentermine. Summary: A 45-year-old woman taking phentermine for weight loss presented with the "worst headache of her life," as well as nausea and...

  • Initial weight loss as a predictor of response to obesity drugs. Dhurandhar, N V; Blank, R C; Schumacher, D; Atkinson, R L // International Journal of Obesity & Related Metabolic Disorders;Dec1999, Vol. 23 Issue 12, p1333 

    BACKGROUND: Initial weight loss has been used as a predictor of long-term response to obesity drugs. Discontinuation of drugs has been recommended if weight loss is not ≥ 1.81 kg (4 Ib) in the first month of treatment. OBJECTIVE: We compared the weight loss response at 6 months of patients...

  • Tracking the `fenphen' drug trend.  // Physician & Sportsmedicine;Sep96, Vol. 24 Issue 9, p17 

    Reports on the popularity of the drugs fenfluramine and phentermine for weight reduction and appetite suppression. Mechanism by which both drugs promote weight loss; Prescription dosages of both drugs; Method by which physicians arrive at a decision to five the fenfluramine-phentermine...

  • GPs should join debate on potential risk versus reward of obesity drug. Castaneda, Reynald // New Zealand Doctor;10/8/2014, p14 

    The article focuses on the debate by general practitioners (GP) and clinicians in New Zealand on the risks and reward of the obesity drug phentermine.

  • Phentermine.  // Reactions Weekly;6/22/2013, Issue 1458, p36 

    The article describes the case of a 59-year-old woman who developed acute interstitial nephritis following treatment with phentermine for weight loss.

  • The Straight Dope On Weight-Loss Drugs. Fentress, Debbie; Agnew, Bruce // Diabetes Forecast;Apr2002, Vol. 55 Issue 4, p51 

    Provides information on weight-loss drugs, Xenical, Meridia and phentermine. Overview of studies on the drugs; Side effects of weight loss drugs; Contents of the drugs. INSET: Beware herbal remedies.

  • FDA Warning on Chinese Diet Pills Containing Fenfluramine.  // FDA Consumer;Sep/Oct2002, Vol. 36 Issue 5, p7 

    Reports on warnings about Chinese weight-loss products from the U.S. Food and Drug Administration. Risks from Chaso Diet Capsules and Chaso Genpi; Deaths in Japan; Danger of the toxic ingredient, aristolochic acid; Lethal combination of fenfluramine and phentermine.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics